News Agency
Men's Weekly

First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level

  • Written by PR Newswire
First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level

HIGHLIGHTS

  • Undetectable levels of Prostate Specific Antigen (PSA) have been reported from the first patient with metastatic castrate-resistant prostate cancer (mCRPC) to ever receive two cycles of Clarity's 67Cu-SAR-bisPSMA at the 8GBq dose level. PSA is a marker of tumour burden, clinical response to treatment and an indicator of the recurrence of...

Read more: First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves...

3PL Companies Powering Efficient Logistics And Scalable Business Growth

Behind every smooth online order and timely delivery, there’s often an invisible engine working tirelessly in the background. That engine is powered by 3PL companies, quietly orchestrating storage, packing, and shipping so businesses can focus on what they do best... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion